OREON Life Science Reshapes the Medical Filler Market with
‘i·NOVA’ – Innovative Technology Draws Attention at Dubai Derma 2025
Oreon Life Science participated in ‘Dubai Derma 2025,’ held at the Dubai World Trade Centre from April 14th to 16th, to showcase its flagship products and accelerate its global market expansion.
As a medical aesthetics specialist with the technology to in-house produce high-purity hyaluronic acid fillers, Oreon Life Science distributes a high-performance product range. This includes skin boosters utilizing ingredients effective for regeneration and whitening—such as glutathione, polynucleotides, amino acids, and chitosan—as well as biostimulators and lipolysis solutions, through collaboration with trusted global partners. Based on a portfolio that addresses various concerns like hydration, elasticity, and regeneration, the company is rapidly expanding its presence in the global market.
At this exhibition, the hybrid HA filler ‘i·NOVA’ was introduced as the main product.
According to the company, i·NOVA combines high and low-molecular weight hyaluronic acid in an optimal ratio, adding collagen-activating ingredients and antioxidant complexes to provide deep hydration and skin regeneration simultaneously. It is characterized by improved treatment efficiency and durability compared to existing fillers, and its 2.5ml large-capacity configuration enhances practitioner convenience. In addition to the i-Series lineup (i-LEAD HA filler, i·JUV PN skin booster) which includes i·NOVA, various other products were displayed, such as ▲PLLA-based biostimulators aesplla and PiNkLLA, ▲PLORE for hydration and lifting, ▲PLOCHI for step-by-step effects from soothing to regeneration, ▲exosome-based skin booster EXOJUV, and ▲lipolysis solution Pink Bottle.
Accelerating Middle East Market Entry through Consultations with Local Distributors
Through this exhibition, Oreon Life Science experienced high demand for high-performance fillers and regenerative solutions through consultations with local buyers. The company stated it is concrete-izing potential distribution collaborations with neighboring countries such as Saudi Arabia, the UAE, and Kuwait. Furthermore, in countries set as mid-to-long-term strategic markets like Brazil, the company is preparing licensing procedures based on partnerships with local pharmaceutical firms, expecting full-scale sales expansion in the Latin American market starting from the second half of the year.
Moving forward, Oreon Life Science plans to expand its hybrid filler product line centered on i·NOVA. Simultaneously, it will strengthen its high-performance skin booster and biostimulator lineups—combining various functions like whitening, regeneration, and antioxidants beyond simple hydration—to continuously expand its global portfolio.
A company official stated, "Based on our experience in obtaining licenses and operating stable supply systems in various countries, we plan to more sophisticatedly pursue registration and distribution strategies optimized for each market." They added, "We also intend to solidify our trust and presence in the global market through collaborations with regional KOLs, academic-based marketing, and branding activities utilizing digital platforms."
👉 https://www.yakup.com/news/index.html?mode=view&cat=12&nid=309153
👉 https://www.startupn.kr/news/articleView.html?idxno=51647
👉 https://www.startupn.kr/news/articleView.html?idxno=51647
OREON Life Science Reshapes the Medical Filler Market with
‘i·NOVA’ – Innovative Technology Draws Attention at Dubai Derma 2025
Oreon Life Science participated in ‘Dubai Derma 2025,’ held at the Dubai World Trade Centre from April 14th to 16th, to showcase its flagship products and accelerate its global market expansion.
As a medical aesthetics specialist with the technology to in-house produce high-purity hyaluronic acid fillers, Oreon Life Science distributes a high-performance product range. This includes skin boosters utilizing ingredients effective for regeneration and whitening—such as glutathione, polynucleotides, amino acids, and chitosan—as well as biostimulators and lipolysis solutions, through collaboration with trusted global partners. Based on a portfolio that addresses various concerns like hydration, elasticity, and regeneration, the company is rapidly expanding its presence in the global market.
At this exhibition, the hybrid HA filler ‘i·NOVA’ was introduced as the main product.
According to the company, i·NOVA combines high and low-molecular weight hyaluronic acid in an optimal ratio, adding collagen-activating ingredients and antioxidant complexes to provide deep hydration and skin regeneration simultaneously. It is characterized by improved treatment efficiency and durability compared to existing fillers, and its 2.5ml large-capacity configuration enhances practitioner convenience. In addition to the i-Series lineup (i-LEAD HA filler, i·JUV PN skin booster) which includes i·NOVA, various other products were displayed, such as ▲PLLA-based biostimulators aesplla and PiNkLLA, ▲PLORE for hydration and lifting, ▲PLOCHI for step-by-step effects from soothing to regeneration, ▲exosome-based skin booster EXOJUV, and ▲lipolysis solution Pink Bottle.
Accelerating Middle East Market Entry through Consultations with Local Distributors
Through this exhibition, Oreon Life Science experienced high demand for high-performance fillers and regenerative solutions through consultations with local buyers. The company stated it is concrete-izing potential distribution collaborations with neighboring countries such as Saudi Arabia, the UAE, and Kuwait. Furthermore, in countries set as mid-to-long-term strategic markets like Brazil, the company is preparing licensing procedures based on partnerships with local pharmaceutical firms, expecting full-scale sales expansion in the Latin American market starting from the second half of the year.
Moving forward, Oreon Life Science plans to expand its hybrid filler product line centered on i·NOVA. Simultaneously, it will strengthen its high-performance skin booster and biostimulator lineups—combining various functions like whitening, regeneration, and antioxidants beyond simple hydration—to continuously expand its global portfolio.
A company official stated, "Based on our experience in obtaining licenses and operating stable supply systems in various countries, we plan to more sophisticatedly pursue registration and distribution strategies optimized for each market." They added, "We also intend to solidify our trust and presence in the global market through collaborations with regional KOLs, academic-based marketing, and branding activities utilizing digital platforms."
👉 https://www.yakup.com/news/index.html?mode=view&cat=12&nid=309153
👉 https://www.startupn.kr/news/articleView.html?idxno=51647
👉 https://www.startupn.kr/news/articleView.html?idxno=51647